
CervoMed Inc.
CRVOHealthcare|Biotechnology|US
$1.42
-0.03 (-2.07%)
DCF Value
$0.80
Tangible Book / Share
$1.15
Cash / Share
$1.30
Ownership Breakdown
63.6%
Float
15.1M
Shares Outstanding
9.6M
Float Shares
Major Holders (10)
Combined: 82.9%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Boger Joshua S | Individual | 20.00% | 2,204,143 | Jun 15, 2026 | 13D/G |
| Armistice Capital, LLC | IA, OO | 9.53% | 1,592,863 | Aug 14, 2026 | 13D/G |
| Steven Boyd | HC, IN | 9.53% | 1,592,863 | Aug 14, 2026 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 8.60% | 1,266,143 | Aug 14, 2026 | 13D/G |
| Rajeev Shah | HC, IN | 8.60% | 1,266,143 | Aug 14, 2026 | 13D/G |
| Peter Kolchinsky | HC, IN | 8.60% | 1,266,143 | Aug 14, 2026 | 13D/G |
| RA Capital Management, L.P. | IA, PN | 8.60% | 1,266,143 | Aug 14, 2026 | 13D/G |
| Woodline Partners LP | IA, PN | 5.10% | 688,987 | Aug 14, 2026 | 13D/G |
| AWM Investment Company, Inc. | Investment adviser | 4.20% | 405,165 | Apr 7, 2026 | 13D/G |
| Morgan Stanley | HC, CO | 0.10% | 12,550 | Jul 8, 2026 | 13D/G |
Insider Trades (78)
Last 4 quarters: 3,441,942 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Blackburn Kelly | EVP, Clinical Development | Oct 22, 2026 | AWARD | 19,100 | $2.24 | $42.8K | Form 4 |
| De Rosch Mark | EVP, RA and GA and PgM | Oct 22, 2026 | AWARD | 19,100 | $2.24 | $42.8K | Form 4 |
| Winton Matthew | Chief Commercial and Business | Oct 22, 2026 | AWARD | 19,100 | $2.24 | $42.8K | Form 4 |
| BOGER JOSHUA S | director, 10 percent owner: | Jun 11, 2026 | BUY | 955,414 | $3.14 | $3.0M | Form 4 |
| BOGER JOSHUA S | director, 10 percent owner: | Jun 11, 2026 | BUY | 955,414 | $3.32 | $3.2M | Form 4 |
| BOGER JOSHUA S | director, 10 percent owner: | Jun 11, 2026 | BUY | 955,414 | $3.14 | $3.0M | Form 4 |
| ZAVRL FRANK | director | Jun 8, 2026 | AWARD | 8,150 | $2.91 | $23.7K | Form 4 |
| Sabbagh Marwan | director | Jun 8, 2026 | AWARD | 8,150 | $2.91 | $23.7K | Form 4 |
| Quigley David | director | Jun 8, 2026 | AWARD | 8,150 | $2.91 | $23.7K | Form 4 |
| Poulton Jeffrey V. | director | Jun 8, 2026 | AWARD | 8,150 | $2.91 | $23.7K | Form 4 |
| Hollingsworth Jane H | director | Jun 8, 2026 | AWARD | 8,150 | $2.91 | $23.7K | Form 4 |
| Gregoire Sylvie | director, 10 percent owner: | Jun 8, 2026 | AWARD | 8,150 | $2.91 | $23.7K | Form 4 |
| BOGER JOSHUA S | director, 10 percent owner: | Jun 8, 2026 | AWARD | 8,150 | $2.91 | $23.7K | Form 4 |
| ALAM JOHN J | director, 10 percent owner, officer: CEO & President | Jun 8, 2026 | AWARD | 8,150 | $2.91 | $23.7K | Form 4 |
| Winton Matthew | Chief Commercial and Business | Feb 11, 2026 | AWARD | 30,000 | $4.80 | $144.0K | Form 4 |
| Gregoire Sylvie | director, 10 percent owner: | Feb 11, 2026 | AWARD | 75,000 | $4.80 | $360.0K | Form 4 |
| ELDER WILLIAM ROBERT | CFO, GC & Secretary | Feb 11, 2026 | AWARD | 30,000 | $4.80 | $144.0K | Form 4 |
| De Rosch Mark | EVP, RA and GA and PgM | Feb 11, 2026 | AWARD | 30,000 | $4.80 | $144.0K | Form 4 |
| Blackburn Kelly | EVP, Clinical Development | Feb 11, 2026 | AWARD | 30,000 | $4.80 | $144.0K | Form 4 |
| ALAM JOHN J | director, 10 percent owner, officer: CEO & President | Feb 11, 2026 | AWARD | 75,000 | $4.80 | $360.0K | Form 4 |
| Quigley David | director | Oct 27, 2025 | AWARD | 16,200 | $7.02 | $113.7K | Form 4 |
| Quigley David | director: | Oct 27, 2025 | OTHER | 0 | — | — | Form 4 |
| Winton Matthew | Chief Commercial and Business | Nov 18, 2025 | BUY | 1,500 | $7.95 | $11.9K | Form 4 |
| Winton Matthew | Chief Commercial and Business | Nov 17, 2025 | BUY | 3,500 | $8.43 | $29.5K | Form 4 |
| Gregoire Sylvie | director, 10 percent owner: | Nov 17, 2025 | BUY | 10,793 | $8.46 | $91.3K | Form 4 |
| Gregoire Sylvie | director, 10 percent owner: | Nov 17, 2025 | BUY | 10,807 | $8.46 | $91.4K | Form 4 |
| ELDER WILLIAM ROBERT | CFO, GC & Secretary | Nov 18, 2025 | BUY | 2,500 | $8.32 | $20.8K | Form 4 |
| ELDER WILLIAM ROBERT | CFO, GC & Secretary | Nov 17, 2025 | BUY | 1,000 | $8.45 | $8.4K | Form 4 |
| ALAM JOHN J | director, 10 percent owner, officer: CEO & President | Nov 17, 2025 | BUY | 10,807 | $8.46 | $91.4K | Form 4 |
| ALAM JOHN J | director, 10 percent owner, officer: CEO & President | Nov 17, 2025 | BUY | 10,793 | $8.46 | $91.3K | Form 4 |
| Gregoire Sylvie | director, 10 percent owner: | Nov 14, 2025 | BUY | 1,707 | $7.57 | $12.9K | Form 4 |
| Gregoire Sylvie | director, 10 percent owner: | Nov 13, 2025 | BUY | 4,447 | $7.51 | $33.4K | Form 4 |
| Gregoire Sylvie | director, 10 percent owner: | Nov 14, 2025 | BUY | 1,693 | $7.55 | $12.8K | Form 4 |
| ALAM JOHN J | director, 10 percent owner, officer: CEO & President | Nov 14, 2025 | BUY | 1,693 | $7.55 | $12.8K | Form 4 |
| ALAM JOHN J | director, 10 percent owner, officer: CEO & President | Nov 13, 2025 | BUY | 4,447 | $7.51 | $33.4K | Form 4 |
| ALAM JOHN J | director, 10 percent owner, officer: CEO & President | Nov 14, 2025 | BUY | 1,707 | $7.57 | $12.9K | Form 4 |
| Winton Matthew | Chief Commercial and Business | Nov 14, 2025 | BUY | 10,000 | $7.57 | $75.7K | Form 4 |
| Gregoire Sylvie | director, 10 percent owner: | Nov 12, 2025 | BUY | 5,553 | $7.35 | $40.8K | Form 4 |
| ELDER WILLIAM ROBERT | CFO, GC & Secretary | Nov 12, 2025 | BUY | 3,500 | $7.44 | $26.0K | Form 4 |
| ALAM JOHN J | director, 10 percent owner, officer: CEO & President | Nov 12, 2025 | BUY | 5,553 | $7.35 | $40.8K | Form 4 |
| Winton Matthew | Chief Commercial and Business | Oct 6, 2025 | AWARD | 75,000 | $8.62 | $646.5K | Form 4 |
| Winton Matthew | officer | Oct 6, 2025 | OTHER | 0 | — | — | Form 4 |
| ALAM JOHN J | director, 10 percent owner, officer: CEO & President | Jun 23, 2025 | AWARD | 8,100 | $6.52 | $52.8K | Form 4 |
| ZAVRL FRANK | director | Jun 23, 2025 | AWARD | 8,100 | $6.52 | $52.8K | Form 4 |
| BOGER JOSHUA S | director, 10 percent owner: | Jun 23, 2025 | AWARD | 8,100 | $6.52 | $52.8K | Form 4 |
| Sabbagh Marwan | director | Jun 23, 2025 | AWARD | 8,100 | $6.52 | $52.8K | Form 4 |
| Poulton Jeffrey V. | director | Jun 23, 2025 | AWARD | 8,100 | $6.52 | $52.8K | Form 4 |
| Hollingsworth Jane H | director | Jun 23, 2025 | AWARD | 8,100 | $6.52 | $52.8K | Form 4 |
| Gregoire Sylvie | director, 10 percent owner: | Jun 23, 2025 | AWARD | 8,100 | $6.52 | $52.8K | Form 4 |
| De Rosch Mark | EVP, RA and GA and PgM | May 1, 2025 | OTHER | 27,000 | $2.30 | $62.1K | Form 4 |
| De Rosch Mark | EVP, RA and GA and PgM | May 1, 2025 | OTHER | 32,000 | $12.53 | $401.0K | Form 4 |
| ELDER WILLIAM ROBERT | CFO, GC & Secretary | May 14, 2025 | BUY | 4,233 | $8.46 | $35.8K | Form 4 |
| Gregoire Sylvie | director, 10 percent owner: | Feb 4, 2025 | AWARD | 60,000 | $2.30 | $138.0K | Form 4 |
| ELDER WILLIAM ROBERT | CFO & GC | Feb 4, 2025 | AWARD | 27,000 | $2.30 | $62.1K | Form 4 |
| Cobuzzi Robert Joseph Jr. | Chief Operating Officer | Feb 4, 2025 | AWARD | 27,000 | $2.30 | $62.1K | Form 4 |
| Blackburn Kelly | SVP, Clinical Development | Feb 4, 2025 | AWARD | 27,000 | $2.30 | $62.1K | Form 4 |
| ALAM JOHN J | director, 10 percent owner, officer: CEO & President | Feb 4, 2025 | AWARD | 60,000 | $2.30 | $138.0K | Form 4 |
| ELDER WILLIAM ROBERT | CFO & GC | Aug 27, 2024 | BUY | 1,000 | $18.16 | $18.2K | Form 4 |
| ALAM JOHN J | director, 10 percent owner, officer: CEO & President | Jun 14, 2024 | AWARD | 5,750 | $19.01 | $109.3K | Form 4 |
| BOGER JOSHUA S | director, 10 percent owner: | Jun 14, 2024 | AWARD | 5,750 | $19.01 | $109.3K | Form 4 |
| Gregoire Sylvie | director, 10 percent owner: | Jun 14, 2024 | AWARD | 5,750 | $19.01 | $109.3K | Form 4 |
| Hollingsworth Jane H | director | Jun 14, 2024 | AWARD | 5,750 | $19.01 | $109.3K | Form 4 |
| Poulton Jeffrey V. | director | Jun 14, 2024 | AWARD | 5,750 | $19.01 | $109.3K | Form 4 |
| Sabbagh Marwan | director | Jun 14, 2024 | AWARD | 5,750 | $19.01 | $109.3K | Form 4 |
| ZAVRL FRANK | director | Jun 14, 2024 | AWARD | 5,750 | $19.01 | $109.3K | Form 4 |
| BOGER JOSHUA S | director, 10 percent owner: | Feb 26, 2024 | X | 495,995 | — | — | Form 4 |
| BOGER JOSHUA S | director, 10 percent owner: | Feb 26, 2024 | SELL | 36 | — | — | Form 4 |
| BOGER JOSHUA S | director, 10 percent owner: | Feb 26, 2024 | DISPOSED | 495,995 | $0.00 | $496.00 | Form 4 |
| BOGER JOSHUA S | director | Feb 12, 2024 | AWARD | 10,000 | $13.97 | $139.7K | Form 4 |
| BOGER JOSHUA S | director | Feb 7, 2024 | OTHER | 0 | — | — | Form 4 |
| BOGER JOSHUA S | director | Feb 7, 2024 | DISPOSED | 0 | — | — | Form 4 |
| BOGER JOSHUA S | director | Feb 7, 2024 | OTHER | 495,995 | — | — | Form 4 |
| ALAM JOHN J | director, 10 percent owner, officer: CEO & President | Jan 26, 2024 | AWARD | 35,500 | $9.05 | $321.3K | Form 4 |
| Blackburn Kelly | SVP, Clinical Development | Jan 26, 2024 | AWARD | 16,000 | $9.05 | $144.8K | Form 4 |
| TANNER JOHN WILLIAM | Chief Financial Officer | Jan 26, 2024 | AWARD | 16,000 | $9.05 | $144.8K | Form 4 |
| ELDER WILLIAM ROBERT | GC & Secretary | Jan 26, 2024 | AWARD | 16,000 | $9.05 | $144.8K | Form 4 |
| Gregoire Sylvie | director, 10 percent owner: | Jan 26, 2024 | AWARD | 35,500 | $9.05 | $321.3K | Form 4 |
| Cobuzzi Robert Joseph Jr. | Chief Operating Officer | Jan 26, 2024 | AWARD | 55,721 | $9.05 | $504.3K | Form 4 |